Table 2.
Preoperative variables analyzed
|
LA + M + K group (n = 38) |
LA + F group (n = 60) |
P value | |
|---|---|---|---|
| Age (y), mean ± SD | 84.4 ± 6.7 | 85.5 ± 6.1 | .411 |
| Male, n (%) | 19 (50) | 30 (50) | 1 |
| BMI (kg/m2), median (range) | 24 (17.6–45) | 22.8 (17–39) | .547 |
| Comorbidity, n (%) | |||
| Cardiac disease | 27 (71.1) | 38 (63.3) | .570 |
| Ischemic cardiac disease | 17 (62.9) | 22 (57.8) | .560 |
| CHF class II or III | 12 (44.4) | 18 (47.3) | .952 |
| COPD requiring LTOT | 17 (44.7) | 29 (48.3) | .888 |
| CNS disease | 10 (26.3) | 26 (43.3) | .137 |
| Stroke | 6 (60) | 16 (61.5) | .313 |
| Neurocognitive disorder | 3 (30) | 9 (34.6) | .466 |
| Parkinson disease | 2 (20) | 5 (19.2) | .863 |
| Complicated type 2 diabetes | 11 (28.9) | 18 (30) | 1 |
| Chronic renal failure | 12 (31.6) | 11 (18.3) | .815 |
| Charlson Comorbidity Index, mean ± SD | 7.5 ± 2.6 | 8 ± 2.6 | .414 |
| ASA score, n (%) | |||
| 2 | 2 (5.3) | 3 (5) | |
| 3 | 29 (76.3) | 40 (66.7) | .537 |
| 4 | 7 (18.4) | 17 (28.3) |
CHF, congestive heart failure; CNS, central nervous system; LTOT, long-term oxygen therapy.